Jan Lindebjerg

Medicine & Life Sciences

1. Colorectal Neoplasms 100%
2. Colonic Neoplasms 89%
3. Rectal Neoplasms 71%
4. Neoplasms 54%
5. MicroRNAs 30%
6. Chemoradiotherapy 28%
7. Circulating Tumor DNA 26%
8. Microsatellite Instability 23%
9. DNA Mismatch Repair 23%
10. Survival 22%
11. Drug Therapy 21%
12. Capecitabine 19%
13. Oxaliplatin 18%
14. Single Nucleotide Polymorphism 18%
15. Adenocarcinoma 17%
16. Vascular Endothelial Growth Factor A 17%
17. Biliary Tract Neoplasms 17%
18. Mutation 16%
19. Immunohistochemistry 16%
20. Denmark 14%
21. Hereditary Nonpolyposis Colorectal Neoplasms 13%
22. Microsatellite Repeats 13%
23. Panitumumab 12%
24. Progression-Free Survival 12%
25. Therapeutics 12%
26. Microvessels 12%
27. Sigmoid Neoplasms 11%
28. Occult Blood 11%
29. Methylation 11%
30. Thymidylate Synthase 11%
31. Population 11%
32. Genes 11%
33. Vascular Endothelial Growth Factor Receptor-2 11%
34. Irinotecan 10%
35. Turcot syndrome 10%
36. Cetuximab 10%
37. Confidence Intervals 10%
38. Biopsy 9%
39. Hematologic Tests 9%
40. Magnetic Resonance Imaging 9%
41. Elasticity Imaging Techniques 9%
42. DNA 9%
43. Diverticulum 9%
44. Neoplasm Metastasis 9%
45. Recurrence 8%
46. Brachytherapy 8%
47. Combination Drug Therapy 8%
48. Tomography 8%
49. Gene Expression 8%
50. Adenoma 8%